Medlive Technology Co., Ltd.
2192.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.88B
Close$
$15.96
142.2% upside
Current Fair Value
142.2% upsideUndervalued by 142.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.88 Billion |
|---|---|
| Enterprise Value | $3.30 Billion |
| Dividend Yield | $0.29 (4.77%) |
| Earnings per Share | $0.45 |
| Beta | 0.44 |
| Outstanding Shares | 738,697,300 |
Return
| Return on Equity | 13.84% |
|---|---|
| Return on Assets | 13.17% |
| Return on Invested Capital | 6.58% |
Valuation & Multiples
| P/E Ratio | 12.2 |
|---|---|
| PEG | 305.46 |
| Price to Sales | 6.59 |
| Price to Book Ratio | 1.1 |
| Enterprise Value to Revenue | 2.59 |
| Enterprise Value to EBIT | 10.3 |
| Enterprise Value to Net Income | 4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 28, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$364.06 M
Average shareholder expectationNext Earnings Call
Expected Date
March 29, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$403.81 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Medlive Technology Co., Ltd.
713 employees
CEO: Liping Tian Medlive Technology Co., Ltd., along with its affiliated entities, manages a digital platform tailored for medical professionals, serving both the Chinese mainland and international markets. Through its comprehensive platform, the company...